Figure 3.

a)An impact of the palladaheterocycle II on duration of hexobarbital sleep (HS); b) an impact of the palladaheterocycle II on changes in AST/ALT ratio upon modeling the acute toxic hepatitis (Note: * Statistically significant differences from the indices of a group of intact animals; ** Statistically significant differences from the indicators of the group “CCl₄”; *** Statistically significant differences from the indicators of the group “CCl₄ + SAM”); c)an impact of the palladaheterocycle II on changes in the bilirubin glucuronic nucleation rate in case of modeling the acute toxic hepatitis (Note: Conjugated bilirubin (BC); Total bilirubin (TB); * Statistically significant differences from the indices of a group of intact animals; ** Statistically significant differences from the indicators of the group “CCl₄”).